Semzuvolimab Chimeric Monoclonal Antibody
Semzuvolimabis a research-grade recombinant antibody targeting CD4. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4
UniProt
P01730
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
7-(4-(4-Chlorobutoxy)butoxy)-3,4-dihydroquinolin-2(1H)-one
Benzyl 2-Acetamido-2-deoxy-4,6-O-benzylidene-a-D-galactopyranoside
